These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 3018648

  • 1. [EPICO in the treatment of small cell bronchial cancer. 3. Intermediate analysis].
    Drings P, Bülzebruck H, Hruska D, Manke HG, Schuler G.
    Onkologie; 1986 Aug; 9 Suppl 1():14-20. PubMed ID: 3018648
    [Abstract] [Full Text] [Related]

  • 2. Epirubicin weekly in combination chemotherapy with cyclophosphamide and vincristine in untreated small cell lung cancer: a phase II trial.
    Kretzschmar A, Drings P.
    Onkologie; 1990 Apr; 13(2):141-2. PubMed ID: 2165228
    [Abstract] [Full Text] [Related]

  • 3. Combination chemotherapy with vincristine, epirubicin and cyclophosphamide in small cell lung carcinoma. Polish Lung Cancer Cooperative Group.
    Jassem J, Karnicka-Młodkowska H, Drozd-Lula M, Strug A, Pilarska-Machowicz A, Michalski A, Kowal E, Moś-Antkowiak R, Zych J.
    Eur J Cancer; 1992 Apr; 28(2-3):473-6. PubMed ID: 1317199
    [Abstract] [Full Text] [Related]

  • 4. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
    Hong WK, Nicaise C, Lawson R, Maroun JA, Comis R, Speer J, Luedke D, Hurtubise M, Lanzotti V, Goodlow J.
    J Clin Oncol; 1989 Apr; 7(4):450-6. PubMed ID: 2538577
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D, Mari D, Graziano F, Isidori P, Cetto G, Pasini F, Santo A, Cellerino R.
    Cancer; 1997 Dec 15; 80(12):2222-9. PubMed ID: 9404698
    [Abstract] [Full Text] [Related]

  • 7. Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancer.
    Kánitz E, Kolaric K, Jassem J, Mechl Z, Pawlicki M, Ringwald G, Rolski J, Schoket Z, Vukas D, Kaplan E.
    Oncology; 1992 Dec 15; 49(5):327-32. PubMed ID: 1326734
    [Abstract] [Full Text] [Related]

  • 8. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D, Graziano F, Mari D, Cetto G, Pasini F, Antonio S, Isidori P, Gasparini S.
    Anticancer Res; 1994 Dec 15; 14(5B):2221-7. PubMed ID: 7840527
    [Abstract] [Full Text] [Related]

  • 9. Cisplatin-VP16 alternating with cyclophosphamide-epirubicin versus cyclophosphamide-epirubicin-vincristine in small cell lung cancer.
    Farris A, Bisail M, Sarobba MG, Sanna G, Scotto T, Valzelli S, Intini C.
    J Chemother; 1993 Oct 15; 5(5):344-7. PubMed ID: 8106908
    [Abstract] [Full Text] [Related]

  • 10. [Adriamycin, cyclophosphamide, vincristine and methotrexate combination chemotherapy of small cell lung cancer].
    Saito H, Kawatsu H, Saka H, Yamamoto M, Takagi E, Tsunekawa H, Kawachi H, Nagura E, Sakai S, Nishiwaki K.
    Gan To Kagaku Ryoho; 1988 Jun 15; 15(6):1909-13. PubMed ID: 2838000
    [Abstract] [Full Text] [Related]

  • 11. Doxorubicin and 4'-epidoxorubicin in combination chemotherapy of extensive small cell lung cancer.
    Nikkanen TA, Jakobsson M, Järvinen M, Liippo K, Ojala A, Paloheimo S, Nordman E.
    Acta Oncol; 1988 Jun 15; 27(1):75-6. PubMed ID: 2835069
    [No Abstract] [Full Text] [Related]

  • 12. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
    Lindgren D, Cadman E, Erichson R, Grann V, Sachs K.
    Cancer Treat Rep; 1984 Sep 15; 68(9):1159-61. PubMed ID: 6090015
    [Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy with cyclophosphamide, epirubicin and etoposide in small cell lung cancer.
    Jassem J, Karnicka-Młodkowska H, Jassem E, Słupek A, Zych J, Wiatr E, Malak S, Moś-Antkowiak R, Szymaczek-Meyer L, Pilarska-Machowicz A.
    Lung Cancer; 1994 Sep 15; 11(3-4):283-91. PubMed ID: 7812705
    [Abstract] [Full Text] [Related]

  • 14. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE, Crowley JJ, Blasko JC, Livingston RB, Beck TM, Demattia MD, Bukowski RM.
    J Clin Oncol; 1990 Jan 15; 8(1):39-47. PubMed ID: 2153194
    [Abstract] [Full Text] [Related]

  • 15. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Hatlevoll R, Dahle R, Boye N, Wang M, Vigander T, Vilsvik J, Skovlund E, Hannisdal E, Aamdal S, Norwegian Lung Cancer Study Group.
    J Clin Oncol; 2002 Dec 15; 20(24):4665-72. PubMed ID: 12488411
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M, Havemann K, Holle R, Gropp C, Drings P, Hans K, Schroeder M, Heim M, Dommes M, Mende S.
    J Clin Oncol; 1987 Dec 15; 5(12):1880-9. PubMed ID: 2824710
    [Abstract] [Full Text] [Related]

  • 17. Addition of etoposide to cyclophosphamide, doxorubicin, and vincristine for remission induction and survival in patients with small cell lung cancer.
    Messeih AA, Schweitzer JM, Lipton A, Harvey HA, Simmonds MA, Stryker JA, Ricci JA, Hoffman SL, Gottleib RJ, Dixon RH.
    Cancer Treat Rep; 1987 Jan 15; 71(1):61-6. PubMed ID: 3024828
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of small cell lung cancer with cyclophosphamide, adriamycin and vincristine (CAV) combination therapy: experience at University Hospital, Kuala Lumpur, Malaysia.
    Lee SM.
    Singapore Med J; 1990 Aug 15; 31(4):317-20. PubMed ID: 2175049
    [Abstract] [Full Text] [Related]

  • 20. [Phase II study with etoposide/vincristine in small cell bronchial cancer (extensive disease)].
    von Pawel J, Wilke H, Vallée D, Dimbeck H, Schmoll HJ.
    Pneumologie; 1990 Feb 15; 44 Suppl 1():582-3. PubMed ID: 1695002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.